Monoclonal Antibody to OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
 
Sponsors and Collaborators
Providence Health & Services
 
Contact
Scot Lary, RN, BSN, MPA
503 215-2604
 
Chris Fountain, RN, BSN, OCN
503 215-2691
 
Investigator
Brendan D Curti, MD
Providence Health & Services
 
ClinicalTrials.gov Identifier